Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Infectious Diseases and Medical Microbiology (2022) Volume 6, Issue 2

Distinguishing proof of the yeasts and assessment of their antifungal vulnerability.

Introduction: Vaginal candidiasis is considered as a fundamental general clinical issue worldwide and its rate has extended nowadays. Lately, improper and lopsided usage of antifungal meds, auto prescription and likewise resistance has caused sedate check. Methods: This assessment went for choosing the in vitro antifungal shortcoming instances of Candida species withdrew from female genital plot at IMS and SUM Hospital in Bhubaneswar, Odisha, India. Two hundred and fourthly five women (age run: 15 years to 49 years) going to the facility were chosen among January and December 2018 in this cross sectional examination. Vaginal smears were assembled using sterile swabs from each part and refined on savoured dextrose agar improved with chloramphenicol l 0.5%; recognizing confirmation of Candida spp. was performed keeping guideline systems. The plate scattering procedure was used for antifungal weakness testing. Results: Out of the 245 vaginal smears assembled, 94 (38.4%) strains of yeast were isolates among which 43 (45.7%) were Candida albicans and 51 (54.3%) were non albicans. The most raised vulnerability of the isolates was seen for nystatin 62 (83.78%), ketoconazole 61 (82.43%) and fluconazole 60 (81.08%). Conclusion: notwithstanding the perceivable resistance of Candida spp. segregates to miconazole and itraconazole, the results show that nystatin, ketoconazole and fluconazole are the meds of choice for the treatment of vaginal candidiasis around here.

Author(s): Oliver Ava

Abstract Full Text PDF

Get the App